Market Tracker

11/21 4:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.77
Delayed Data
As of 4:00pm ET
 +0.02 / +1.14%
Today’s Change
1.35
Today|||52-Week Range
4.69
-29.20%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close1.75
Today’s open1.70
Day’s range1.69 - 1.79
Volume109,905
Average volume (3 months)488,734
Market cap$35.9M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book5.07

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...-0.01-0.72%
CTRVContraVir Pharmaceut...+0.02+4.42%
PPHMPPeregrine Pharmaceut...-0.13-0.52%
PRPHProPhase Labs Inc-0.02-0.88%
Data as of 4:00pm ET, 11/21/2017

Financials

Last reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts